Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Background: Continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) are the standard of care for type 1 diabetes in children. There is little reported on device-related skin complications and treatment options. This study documents cutaneous reactions to CGM and CSII devices in children and young adults with type 1 diabetes. Methods: One hundred and twenty-one subjects (3-25 years) with type 1 diabetes and CGM and/or CSII use were recruited over a three-month period from the Naomi Berrie Diabetes Center at Columbia University Irving Medical Center. A five-question survey was completed for each subject detailing demographic data, diabetes management, and device-related skin complications. Results: Sixty percent of subjects reported skin complications related to CGM and/or CSII use. Terms most frequently used to describe cutaneous reactions were “red,” “itchy,” “painful,” and “rash.” Subjects who used both CGM and CSII were more likely to report skin problems than those who used only CSII (odds ratio 2.9, [95% confidence interval: 1.2-6.7]; P = .015). There were no associations between skin complications and sex or race/ethnicity. Twenty-two percent of subjects with adverse skin event(s) discontinued use of a device due to their skin problem. Seven percent were evaluated by a dermatologist. Eighty-one percent used a range of products to treat their symptoms, with variable perceived clinical outcomes. Conclusions: Skin complications related to CSII or CGM devices are commonly reported in pediatric patients with type 1 diabetes and may lead to interruption or discontinuation of device use. Future studies are needed to elucidate the causes of these reactions and determine the best methods for prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, insulin infusion set (IIS) failures are common among individuals using insulin pump therapy.3–5”
From Clinical utility of the twiist Automated Insulin Delivery System: first study with twiist (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“Contact dermatitis (both irritant and allergic) has been reported with all devices that attach to the skin (20,117,118).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
Misso, M. L., Egberts, K. J., Page, M., O'Connor, D., & Shaw, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005103.pub2 · Cited by 406
Polonsky, W. H., Hessler, D., Ruedy, K. J., & Beck, R. W. (2017) · Diabetes Care · doi:10.2337/dc17-0133 · Cited by 346 · cited 3×
“15(4) 786 –791 © 2020 Diabetes Technology Society Article reuse guidelines: sagepub.”
BackgroundInfluentialReal-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Herman, A., Aerts, O., Baeck, M., Bruze, M., De Block, C., Goossens, A., Hamnerius, N., Huygens, S., Maiter, D., Tennstedt, D., et al. (2017) · Contact Dermatitis · doi:10.1111/cod.12866 · Cited by 192
Dermatological Complications of Continuous Subcutaneous Insulin Infusion in Children and Adolescents
Conwell, L. S., Pope, E., Artiles, A. M., Mohanta, A., Daneman, A., & Daneman, D. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.10.006 · Cited by 111
Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results
Toffanin, C., Visentin, R., Messori, M., Palma, F. D., Magni, L., & Cobelli, C. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2652062 · Cited by 107
High frequencies of dermatological complications in children using insulin pumps or sensors
Berg, A. K., Olsen, B. S., Thyssen, J. P., Zachariae, C., Simonsen, A. B., Pilgaard, K., & Svensson, J. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12652 · Cited by 96
Allergic contact dermatitis caused by medical devices for diabetes patients: A review
Herman, A., de Montjoye, L., Tromme, I., Goossens, A., & Baeck, M. (2018) · Contact Dermatitis · doi:10.1111/cod.13120 · Cited by 95
Raison‐Peyron, N., Mowitz, M., Bonardel, N., Aerts, O., & Bruze, M. (2018) · Contact Dermatitis · doi:10.1111/cod.12995 · Cited by 87
Berg, A. K., Nørgaard, K., Thyssen, J. P., Zachariae, C., Hommel, E., Rytter, K., & Svensson, J. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0088 · Cited by 87
Allergic contact dermatitis caused by glucose sensors in type 1 diabetes patients
Hyry, H. S. I., Liippo, J. P., & Virtanen, H. M. (2019) · Contact Dermatitis · doi:10.1111/cod.13337 · Cited by 86
Kamann, S., Aerts, O., & Heinemann, L. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818762946 · Cited by 85
Asarani, N. A. M., Reynolds, A. N., Boucher, S. E., de Bock, M., & Wheeler, B. J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819870849 · Cited by 81
N,N‐dimethylacrylamide—A new sensitizer in the FreeStyle Libre glucose sensor
Mowitz, M., Herman, A., Baeck, M., Isaksson, M., Antelmi, A., Hamnerius, N., Pontén, A., & Bruze, M. (2019) · Contact Dermatitis · doi:10.1111/cod.13243 · Cited by 80
Skin and Adhesive Issues With Continuous Glucose Monitors: A Sticky Situation
Englert, K., Ruedy, K., Coffey, J., Caswell, K., Steffen, A., Levandoski, L., for the Diabetes Research in Children (DirecNet) Study Group, Tsalikian, E., Tansey, M. J., Coffey, J., et al. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814529893 · Cited by 77
Adhesives Used for Diabetes Medical Devices: A Neglected Risk With Serious Consequences?
Heinemann, L., & Kamann, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816662949 · Cited by 74
The Dexcom glucose monitoring system—An isobornyl acrylate‐free alternative for diabetic patients
Oppel, E. M., Kamann, S., Reichl, F., & Högg, C. (2019) · Contact Dermatitis · doi:10.1111/cod.13248 · Cited by 69
Peeters, C., Herman, A., Goossens, A. E., Bruze, M., Mowitz, M., & Baeck, M. (2017) · Contact Dermatitis · doi:10.1111/cod.12873 · Cited by 58
Herman, A., Baeck, M., de Montjoye, L., Bruze, M., Giertz, E., Goossens, A. E., & Mowitz, M. (2019) · Contact Dermatitis · doi:10.1111/cod.13374 · Cited by 57
Davis, M. D. P., & Stuart, M. J. (2016) · Dermatitis · doi:10.1097/der.0000000000000163 · Cited by 56
Cressey, B. D., Belum, V. R., Scheinman, P. L., Silvestri, D. L., McEntee, N., Livingston, V., Lacouture, M. E., & Zippin, J. H. (2016) · Contact Dermatitis · doi:10.1111/cod.12678 · Cited by 56
Binder, E. B., Lange, O., Edlinger, M., Meraner, D., Abt, D., Moser, C. E., Steichen, E., & Hofer, S. E. (2015) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0034-1394381 · Cited by 54
Oppel, E. M., Högg, C., Summer, B., Ruëff, F., Reichl, F., & Kamann, S. (2018) · Contact Dermatitis · doi:10.1111/cod.13017 · Cited by 51
Pleus, S., Ulbrich, S., Zschornack, E., Kamann, S., Haug, C., & Freckmann, G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0171 · Cited by 47
Two decades of occupational (meth)acrylate patch test results and focus on isobornyl acrylate
Christoffers, W. A., Coenraads, P., & Schuttelaar, M. A. (2013) · Contact Dermatitis · doi:10.1111/cod.12023 · Cited by 46
Allergic contact dermatitis caused by Dermabond®
Lefèvre, S., Valois, A., & Truchetet, F. (2016) · Contact Dermatitis · doi:10.1111/cod.12597 · Cited by 42
Cutaneous Adverse Effects of Diabetes Mellitus Medications and Medical Devices: A Review
Jedlowski, P. M., Te, C., Segal, R. J., & Fazel, M. T. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-018-0400-7 · Cited by 41
Continuous Glucose Monitoring in Youth with Type 1 Diabetes
Wadwa, R. P., Fiallo-Scharer, R. V., VanderWel, B., Messer, L. H., Cobry, E. C., & Chase, H. P. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0122 · Cited by 36
Kamann, S., & Oppel, E. M. (2019) · Contact Dermatitis · doi:10.1111/cod.13329 · Cited by 34
Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes
Haviland, N., Walsh, J. S. A., Roberts, R., & Bailey, T. S. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0808-5 · Cited by 30
Allergic contact dermatitis caused by isobornyl acrylate when using the FreeStyle® Libre
Mine, Y., Urakami, T., & Matsuura, D. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13023 · Cited by 29
Contact Dermatitis from Dermabond
Howard, B. K., & Downey, S. E. (2010) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181d62a56 · Cited by 25
Corazza, M., Scuderi, V., Musmeci, D., Foti, C., Romita, P., & Borghi, A. (2018) · Contact Dermatitis · doi:10.1111/cod.13075 · Cited by 24
Allergic Contact Dermatitis after Repeated Exposure to Dermabond TM
Caton, A. M., & Dauphine, C. (2014) · The American Surgeon · doi:10.1177/000313481408000529 · Cited by 21
Jacobs, M., Gilissen, L., Vandevenne, A., & Goossens, A. E. (2015) · Contact Dermatitis · doi:10.1111/cod.12438 · Cited by 6
Cited by
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
Metadata
- Authors
- Rigo, R. S., Levin, L. E., Belsito, D. V., Garzon, M. C., Gandica, R., & Williams, K. M.
- Affiliations
- Columbia University Irving Medical Center (US)
- Columbia University Irving Medical Center, New York, NY, USA
- Corresponding author
- Williams, Kristen M.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2020-05-09
- Volume
- 15
- Issue
- 4
- Pages
- 786-791
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC8258506
- OpenAlex
- W3023756006
- Cited by
- 58
- References
- 36
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 10 · 2023: 5 · 2022: 7 · 2021: 4 · 2020: 2
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, insulin pump therapy, type 1 diabetes, skin reactions, pediatric diabetes, young adults, device discontinuation, symptom management
- MeSH terms
- Blood Glucose, Child, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Blood Glucose Self-Monitoring, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.